Clinical trials
Phase 1 Cytomegalovirus Infections trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Terminated | 4 |
| Recruiting | 3 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 8 |
| City of Hope Medical Center | 4 |
| Baylor College of Medicine | 3 |
| Hoffmann-La Roche | 3 |
| ModernaTX, Inc. | 3 |
| Milton S. Hershey Medical Center | 2 |
| Sandoz | 2 |
| University of Wisconsin, Madison | 2 |
| AlloVir | 1 |
| AlphaVax, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cytomegalovirus Infections | 41 |
| HIV Infections | 10 |
| Acquired Immunodeficiency Syndrome | 9 |
| Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 7 |
| Adenoviridae Infections | 6 |
| AIDS-Related Opportunistic Infections | 5 |
| Cytomegalovirus Retinitis | 5 |
| Retinitis | 5 |
| Epstein-Barr Virus Infections | 4 |
| Virus Diseases | 3 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.